Most women clear the infection without treatment, and since she has a lower-risk type and is in her 60s, she is even less ...
Probability of Remaining Event-Free at Three Years by Kaplan-Meier Analysis After Achieving Complete Response at Three MonthsFirst and Only FDA-Approved Medicine for Recurrent Low-Grade ...
Itay: Researchers have found in a new study that a single postoperative dose of Mitomycin C significantly reduces early ...
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), the event-driven ...
CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.
When analyzing spermatozoa in semen microscopy, several parameters are assessed to evaluate male fertility and reproductive ...
Local therapy in HCC brain metastases was linked to longer survival versus supportive care alone. Find out more about the ...
Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with muscle-invasive bladder cancer (MIBC).
A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results